$NKTR
Nektar Therapeutics

2017 Q1 Form 10-K Financial Statement

#000156459017003064 Filed on March 01, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q4 2016
Revenue $24.73M $37.45M $55.35M
YoY Change -58.0% -4.88% -76.01%
Cost Of Revenue $6.131M $6.604M $30.22M
YoY Change -30.88% -21.04% -11.39%
Gross Profit $18.60M $30.85M $25.14M
YoY Change -62.81% -0.52% -87.22%
Gross Profit Margin 75.21% 82.37% 45.41%
Selling, General & Admin $12.00M $12.80M $44.30M
YoY Change 17.65% -3.03% 2.31%
% of Gross Profit 64.53% 41.5% 176.22%
Research & Development $61.06M $50.23M $203.8M
YoY Change 23.93% 6.57% 11.49%
% of Gross Profit 328.32% 162.85% 810.7%
Depreciation & Amortization $4.000M $3.900M $13.20M
YoY Change 8.11% 2.63% 15.79%
% of Gross Profit 21.51% 12.64% 52.51%
Operating Expenses $61.06M $50.23M $203.8M
YoY Change 23.93% 6.57% -9.82%
Operating Profit -$54.44M -$32.15M -$112.9M
YoY Change 473.99% 9.47% 284.24%
Interest Expense $5.402M -$9.600M $22.47M
YoY Change -4.84% -10.28% 22.9%
% of Operating Profit
Other Income/Expense, Net -$9.296M -$39.79M
YoY Change -5.6% -22.43%
Pretax Income -$63.73M -$41.80M -$152.6M
YoY Change 229.69% -22.74% 89.22%
Income Tax $133.0K $400.0K $876.0K
% Of Pretax Income
Net Earnings -$63.87M -$42.20M -$153.5M
YoY Change 227.55% -22.05% 89.12%
Net Earnings / Revenue -258.27% -112.68% -277.35%
Basic Earnings Per Share -$0.42 -$0.28
Diluted Earnings Per Share -$0.42 -$0.28 -$1.100M
COMMON SHARES
Basic Shares Outstanding 153.8M 152.8M
Diluted Shares Outstanding 139.6M

Balance Sheet

Concept 2017 Q1 2016 Q4 2016
SHORT-TERM ASSETS
Cash & Short-Term Investments $358.5M $389.1M $389.1M
YoY Change 24.35% 25.96% 25.96%
Cash & Equivalents $23.48M $59.64M $59.60M
Short-Term Investments $335.0M $329.5M $329.5M
Other Short-Term Assets $7.900M $10.36M $10.10M
YoY Change 41.07% 5.59% 3.06%
Inventory $13.00M $11.11M $11.10M
Prepaid Expenses
Receivables $1.600M $15.68M $15.70M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $381.0M $426.3M $426.0M
YoY Change 10.5% 21.77% 21.68%
LONG-TERM ASSETS
Property, Plant & Equipment $66.64M $65.60M $65.60M
YoY Change -4.66% -8.04% -7.99%
Goodwill $76.50M $76.50M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $3.500M $0.00
YoY Change
Other Assets $865.0K $817.0K $800.0K
YoY Change 23.57% 8.36% 0.0%
Total Long-Term Assets $147.5M $142.6M $142.9M
YoY Change 0.26% -4.02% -3.77%
TOTAL ASSETS
Total Short-Term Assets $381.0M $426.3M $426.0M
Total Long-Term Assets $147.5M $142.6M $142.9M
Total Assets $528.5M $568.9M $568.9M
YoY Change 7.44% 14.08% 14.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.951M $2.816M $2.800M
YoY Change 202.22% 19.17% 16.67%
Accrued Expenses $29.60M $35.10M $35.10M
YoY Change -4.82% 55.31% 55.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.900M
YoY Change -39.58%
Total Short-Term Liabilities $78.52M $72.22M $72.20M
YoY Change 19.06% 17.92% 17.97%
LONG-TERM LIABILITIES
Long-Term Debt $245.5M $243.5M $243.5M
YoY Change 0.0% 0.29% 0.29%
Other Long-Term Liabilities $4.116M $5.000M $165.1M
YoY Change -37.03% -48.67% -12.27%
Total Long-Term Liabilities $4.116M $5.000M $408.6M
YoY Change -37.03% -48.67% -5.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $78.52M $72.22M $72.20M
Total Long-Term Liabilities $4.116M $5.000M $408.6M
Total Liabilities $483.7M $480.7M $480.7M
YoY Change -1.71% -2.33% -2.34%
SHAREHOLDERS EQUITY
Retained Earnings -$2.085B -$2.021B
YoY Change 10.5% 8.22%
Common Stock $2.132B $2.111B
YoY Change 12.88% 12.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $44.75M $88.13M $88.10M
YoY Change
Total Liabilities & Shareholders Equity $528.5M $568.9M $568.9M
YoY Change 7.44% 14.08% 14.1%

Cashflow Statement

Concept 2017 Q1 2016 Q4 2016
OPERATING ACTIVITIES
Net Income -$63.87M -$42.20M -$153.5M
YoY Change 227.55% -22.05% 89.12%
Depreciation, Depletion And Amortization $4.000M $3.900M $13.20M
YoY Change 8.11% 2.63% 15.79%
Cash From Operating Activities -$34.60M -$52.40M -$117.0M
YoY Change 46.61% -30.23% 60.09%
INVESTING ACTIVITIES
Capital Expenditures $4.089M -$2.700M $6.392M
YoY Change 143.54% 8.0% -42.9%
Acquisitions
YoY Change
Other Investing Activities -$9.000M -$139.4M -$76.00M
YoY Change -123.75% 2865.96% 2351.61%
Cash From Investing Activities -$13.10M -$142.1M -$82.40M
YoY Change -136.19% 1873.61% 476.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $189.7M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 11.20M 190.9M 203.6M
YoY Change 154.55% 60.29% 55.67%
NET CHANGE
Cash From Operating Activities -34.60M -52.40M -117.0M
Cash From Investing Activities -13.10M -142.1M -82.40M
Cash From Financing Activities 11.20M 190.9M 203.6M
Net Change In Cash -36.50M -3.600M 4.070M
YoY Change -314.71% -109.78% -90.62%
FREE CASH FLOW
Cash From Operating Activities -$34.60M -$52.40M -$117.0M
Capital Expenditures $4.089M -$2.700M $6.392M
Free Cash Flow -$38.69M -$49.70M -$123.4M
YoY Change 53.05% -31.54% 46.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
153831047
CY2016Q2 dei Entity Public Float
EntityPublicFloat
1935384918
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55570000
CY2015Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
253374000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19947000
CY2015Q4 us-gaap Inventory Net
InventoryNet
11346000
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9814000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
65601000
CY2016Q4 us-gaap Goodwill
Goodwill
76501000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
517000
CY2016Q4 us-gaap Assets
Assets
568871000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2816000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18280000
CY2016Q4 nktr Accrued Clinical Trial Expenses
AccruedClinicalTrialExpenses
7958000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4711000
CY2016Q4 us-gaap Interest Payable Current
InterestPayableCurrent
4198000
CY2016Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2908000
CY2015Q4 nktr Liability For Refundable Upfront Payment
LiabilityForRefundableUpfrontPayment
0
CY2016 us-gaap Interest Expense
InterestExpense
22468000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71336000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
426252000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
350051000
CY2015Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
4756000
CY2016Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
2223000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
51887000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5000000
CY2016Q4 us-gaap Liabilities
Liabilities
480746000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
15000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2111483000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2363000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2021010000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
88125000
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
10363000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9976000
CY2015 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
32208000
CY2014 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
46984000
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
28533000
CY2014 us-gaap Revenues
Revenues
200707000
CY2016 nktr Non Cash Royalty Revenue Related To Sale Of Future Royalties
NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties
30158000
CY2015Q4 us-gaap Assets
Assets
498642000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2363000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5998000
CY2015Q4 nktr Accrued Clinical Trial Expenses
AccruedClinicalTrialExpenses
8220000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4156000
CY2016Q4 nktr Liability For Refundable Upfront Payment
LiabilityForRefundableUpfrontPayment
12500000
CY2016Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
329462000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15678000
CY2016Q4 us-gaap Inventory Net
InventoryNet
11109000
CY2015Q4 us-gaap Goodwill
Goodwill
76501000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
754000
CY2015Q4 us-gaap Interest Payable Current
InterestPayableCurrent
4198000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4499000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
72222000
CY2016Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
243464000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59640000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
14352000
CY2015 nktr Non Cash Interest Expense Related To Sale Of Royalties
NonCashInterestExpenseRelatedToSaleOfRoyalties
20619000
CY2016 nktr Non Cash Interest Expense Related To Sale Of Royalties
NonCashInterestExpenseRelatedToSaleOfRoyalties
19712000
CY2014 nktr Non Cash Interest Expense Related To Sale Of Royalties
NonCashInterestExpenseRelatedToSaleOfRoyalties
20888000
CY2015 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-14079000
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-51300000
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-37943000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-80671000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-152648000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54428000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
506000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
876000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-81177000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-153524000
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.10
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-29371000
CY2016 us-gaap Costs And Expenses
CostsAndExpenses
278291000
CY2014 us-gaap Interest Expense
InterestExpense
17869000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-39793000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-112855000
CY2014 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1680000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-512000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-53916000
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.61
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
132458000
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
126873000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2387000
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
139596000
CY2016 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
79000
CY2015 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
-226000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19669000
CY2014 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
-95000
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-272000
CY2015 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-377000
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-193000
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-603000
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-386000
CY2015Q4 nktr Liability Related To Sale Of Potential Future Royalties Non Current
LiabilityRelatedToSaleOfPotentialFutureRoyaltiesNonCurrent
119032000
CY2016 nktr Proceeds From Sale Of Potential Future Royalties
ProceedsFromSaleOfPotentialFutureRoyalties
0
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
117200000
CY2016Q4 nktr Share Based Compensation Arrangement By Share Based Payment Award Options And Restricted Stock Units Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRestrictedStockUnitsOutstanding
21660000
CY2016Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
12.01
CY2016Q4 nktr Number Of Securities Available For Issuance Under Equity Compensation Plans
NumberOfSecuritiesAvailableForIssuanceUnderEquityCompensationPlans
3113000
CY2015 us-gaap Interest Expense
InterestExpense
18282000
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
55354000
CY2014 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-291000
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Trading Symbol
TradingSymbol
NKTR
CY2016 dei Entity Registrant Name
EntityRegistrantName
NEKTAR THERAPEUTICS
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0000906709
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015 us-gaap Revenues
Revenues
230784000
CY2015Q4 us-gaap Capital Leases Balance Sheet Assets By Major Class Net
CapitalLeasesBalanceSheetAssetsByMajorClassNet
3200000
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
2339000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
21428000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
10127000
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
61246000
CY2015Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
241699000
CY2015Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
1073000
CY2016Q4 nktr Liability Related To Sale Of Potential Future Royalties Non Current Net Of Issuance Costs
LiabilityRelatedToSaleOfPotentialFutureRoyaltiesNonCurrentNetOfIssuanceCosts
105950000
CY2015Q4 nktr Liability Related To Sale Of Potential Future Royalties Non Current Net Of Issuance Costs
LiabilityRelatedToSaleOfPotentialFutureRoyaltiesNonCurrentNetOfIssuanceCosts
116029000
CY2016Q4 nktr Preferred Stock Share Designated
PreferredStockShareDesignated
0
CY2015Q4 nktr Preferred Stock Share Designated
PreferredStockShareDesignated
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
62426000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9740000
CY2015Q4 us-gaap Liabilities
Liabilities
492213000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
13000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1876072000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2170000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1867486000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
6429000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
568871000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
498642000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
153212000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
135289000
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
153212000
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
135289000
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
40155000
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
25152000
CY2016 us-gaap Royalty Revenue
RoyaltyRevenue
19542000
CY2015 us-gaap Royalty Revenue
RoyaltyRevenue
2967000
CY2014 us-gaap Royalty Revenue
RoyaltyRevenue
329000
CY2015 nktr Non Cash Royalty Revenue Related To Sale Of Future Royalties
NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties
22058000
CY2014 nktr Non Cash Royalty Revenue Related To Sale Of Future Royalties
NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties
21937000
CY2016 nktr License Collaboration Other Revenue
LicenseCollaborationOtherRevenue
60382000
CY2015 nktr License Collaboration Other Revenue
LicenseCollaborationOtherRevenue
165604000
CY2014 nktr License Collaboration Other Revenue
LicenseCollaborationOtherRevenue
153289000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-89903000
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
116536000
CY2014 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
46984000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17017000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
36332000
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
32208000
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
189276000
CY2016 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20287000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25850000
CY2014 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
617000
CY2016 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
439000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25850000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19669000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17017000
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15351000
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12855000
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12927000
CY2016 nktr Loss From Redemption Premium And Incremental Interest On Secured Debt
LossFromRedemptionPremiumAndIncrementalInterestOnSecuredDebt
0
CY2015 nktr Loss From Redemption Premium And Incremental Interest On Secured Debt
LossFromRedemptionPremiumAndIncrementalInterestOnSecuredDebt
12500000
CY2014 nktr Loss From Redemption Premium And Incremental Interest On Secured Debt
LossFromRedemptionPremiumAndIncrementalInterestOnSecuredDebt
0
CY2016 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0
CY2015 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
1579000
CY2014 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0
CY2016 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2185000
CY2015 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2365000
CY2014 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
560000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4269000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16340000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1378000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-237000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1606000
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-500000
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
312000
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
825000
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3294000
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
518000
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-412000
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6359000
CY2016 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
12282000
CY2015 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
249000
CY2014 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-8505000
CY2016 nktr Increase Decrease In Accrued Clinical Trial Expenses
IncreaseDecreaseInAccruedClinicalTrialExpenses
-262000
CY2015 nktr Increase Decrease In Accrued Clinical Trial Expenses
IncreaseDecreaseInAccruedClinicalTrialExpenses
512000
CY2014 nktr Increase Decrease In Accrued Clinical Trial Expenses
IncreaseDecreaseInAccruedClinicalTrialExpenses
-9197000
CY2016 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
191000
CY2015 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-2278000
CY2014 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
273000
CY2016 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0
CY2015 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-2719000
CY2014 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0
CY2016 nktr Increase Decrease In Refundable Upfront Payment Liabilities
IncreaseDecreaseInRefundableUpfrontPaymentLiabilities
12500000
CY2015 nktr Increase Decrease In Refundable Upfront Payment Liabilities
IncreaseDecreaseInRefundableUpfrontPaymentLiabilities
0
CY2014 nktr Increase Decrease In Refundable Upfront Payment Liabilities
IncreaseDecreaseInRefundableUpfrontPaymentLiabilities
0
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-17615000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-17530000
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-4664000
CY2016 nktr Increase Decrease In Milestone Payment Liabilities
IncreaseDecreaseInMilestonePaymentLiabilities
0
CY2015 nktr Increase Decrease In Milestone Payment Liabilities
IncreaseDecreaseInMilestonePaymentLiabilities
0
CY2014 nktr Increase Decrease In Milestone Payment Liabilities
IncreaseDecreaseInMilestonePaymentLiabilities
-70000000
CY2016 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-3878000
CY2015 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3032000
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-13801000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-117024000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-73083000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-142006000
CY2016 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
334659000
CY2015 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
297608000
CY2014 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
297251000
CY2016 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
253682000
CY2015 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
226923000
CY2014 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
247995000
CY2016 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
4969000
CY2015 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
42544000
CY2014 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
21661000
CY2016 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0
CY2015 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-25000000
CY2014 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6392000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11195000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-82400000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-14336000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-37571000
CY2016 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
5945000
CY2015 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
5187000
CY2014 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
3536000
CY2016 nktr Proceeds From Issuance Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
189276000
CY2015 nktr Proceeds From Issuance Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
0
CY2014 nktr Proceeds From Issuance Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
116536000
CY2016 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
20287000
CY2016 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0
CY2015 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
241262000
CY2014 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0
CY2016 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0
CY2015 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
125000000
CY2014 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0
CY2016 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0
CY2015 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
12500000
CY2014 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0
CY2016 nktr Repayment Of And Proceeds From Sale Of Future Royalties Net Of Transaction Costs
RepaymentOfAndProceedsFromSaleOfFutureRoyaltiesNetOfTransactionCosts
0
CY2015 nktr Repayment Of And Proceeds From Sale Of Future Royalties Net Of Transaction Costs
RepaymentOfAndProceedsFromSaleOfFutureRoyaltiesNetOfTransactionCosts
0
CY2014 nktr Repayment Of And Proceeds From Sale Of Future Royalties Net Of Transaction Costs
RepaymentOfAndProceedsFromSaleOfFutureRoyaltiesNetOfTransactionCosts
-7000000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
203618000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
130783000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
152984000
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-124000
CY2015 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-159000
CY2014 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-109000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4070000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
43205000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-26702000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12365000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39067000
CY2016 us-gaap Interest Paid
InterestPaid
20589000
CY2015 us-gaap Interest Paid
InterestPaid
20225000
CY2014 us-gaap Interest Paid
InterestPaid
17445000
CY2016 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
757000
CY2015 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
860000
CY2014 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
964000
CY2016 nktr Property And Equipment Acquired Through Capital Leases And Other Financing
PropertyAndEquipmentAcquiredThroughCapitalLeasesAndOtherFinancing
1568000
CY2015 nktr Property And Equipment Acquired Through Capital Leases And Other Financing
PropertyAndEquipmentAcquiredThroughCapitalLeasesAndOtherFinancing
93000
CY2014 nktr Property And Equipment Acquired Through Capital Leases And Other Financing
PropertyAndEquipmentAcquiredThroughCapitalLeasesAndOtherFinancing
5231000
CY2015Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
5100000
CY2016 us-gaap Depreciation
Depreciation
13200000
CY2016 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Certain items previously reported in specific financial statement captions have been reclassified to conform to the current period presentation, including as a result of the adoption of new accounting guidance related to the classification of debt issuance costs described below. Such reclassifications do not materially impact previously reported revenue, operating loss, net loss, total assets, liabilities or stockholders&#8217; equity. </p></div>
CY2016Q4 nktr Cash Restricted Cash Cash Equivalents And Available For Sale Investments
CashRestrictedCashCashEquivalentsAndAvailableForSaleInvestments
389102000
CY2016Q4 us-gaap Senior Notes
SeniorNotes
250000000
CY2016Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
255100000
CY2016Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
5100000
CY2016Q4 nktr Number Of Customers Accounted For Major Accounts Receivable
NumberOfCustomersAccountedForMajorAccountsReceivable
3
CY2015Q4 nktr Number Of Customers Accounted For Major Accounts Receivable
NumberOfCustomersAccountedForMajorAccountsReceivable
3
CY2016 nktr Percentage Of Accounts Receivable Customers One
PercentageOfAccountsReceivableCustomersOne
0.39
CY2015 nktr Percentage Of Accounts Receivable Customers One
PercentageOfAccountsReceivableCustomersOne
0.50
CY2016 nktr Percentage Of Accounts Receivable Customers Two
PercentageOfAccountsReceivableCustomersTwo
0.32
CY2015 nktr Percentage Of Accounts Receivable Customers Two
PercentageOfAccountsReceivableCustomersTwo
0.35
CY2016 nktr Percentage Of Accounts Receivable Customers Three
PercentageOfAccountsReceivableCustomersThree
0.13
CY2015 nktr Percentage Of Accounts Receivable Customers Three
PercentageOfAccountsReceivableCustomersThree
0.10
CY2016 nktr Number Of Reporting Units To Evaluate Goodwill For Impairment
NumberOfReportingUnitsToEvaluateGoodwillForImpairment
1
CY2016 nktr Percentage Of Amount Realized Upon Ultimate Settlement
PercentageOfAmountRealizedUponUltimateSettlement
0.50
CY2015Q4 nktr Cash Restricted Cash Cash Equivalents And Available For Sale Investments
CashRestrictedCashCashEquivalentsAndAvailableForSaleInvestments
308944000
CY2016 nktr Debt Investment Maximum Maturity Period
DebtInvestmentMaximumMaturityPeriod
Two years or less
CY2016 nktr Debt Investment Maturity Date Description
DebtInvestmentMaturityDateDescription
One year or less
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
330713000
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
250444000
CY2016Q4 nktr Cash And Restricted Cash
CashAndRestrictedCash
4355000
CY2015Q4 nktr Cash And Restricted Cash
CashAndRestrictedCash
1842000
CY2016Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2015Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2014Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2016Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2015Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2014Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2016Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
2400000
CY2015Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
2400000
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2055000
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3236000
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
7311000
CY2015Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6087000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1743000
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2023000
CY2016Q4 nktr Depreciable Property Plant And Equipment Gross
DepreciablePropertyPlantAndEquipmentGross
173388000
CY2015Q4 nktr Depreciable Property Plant And Equipment Gross
DepreciablePropertyPlantAndEquipmentGross
165592000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
111243000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
102712000
CY2016Q4 nktr Depreciable Property Plant And Equipment Net
DepreciablePropertyPlantAndEquipmentNet
62145000
CY2015Q4 nktr Depreciable Property Plant And Equipment Net
DepreciablePropertyPlantAndEquipmentNet
62880000
CY2016Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
3456000
CY2015Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
8456000
CY2015 us-gaap Depreciation
Depreciation
11400000
CY2014 us-gaap Depreciation
Depreciation
11700000
CY2016 nktr Redemption Price As Percentage Of Principal Amount In Case Of Change Of Control
RedemptionPriceAsPercentageOfPrincipalAmountInCaseOfChangeOfControl
1.01
CY2016 nktr Redemption Price As Percentage Of Principal Amount In Case Of Sale Of Assets
RedemptionPriceAsPercentageOfPrincipalAmountInCaseOfSaleOfAssets
1.00
CY2016Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
8200000
CY2016Q4 us-gaap Capital Leases Balance Sheet Assets By Major Class Net
CapitalLeasesBalanceSheetAssetsByMajorClassNet
7400000
CY2016 nktr Capital Leases Termination Date
CapitalLeasesTerminationDate
2016-10-05
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
3270000
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
5609000
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
478000
CY2016Q4 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
5131000
CY2016 nktr Sublease Term Commenced Start Date
SubleaseTermCommencedStartDate
2010-08
CY2016 nktr Sublease Term Commenced Period
SubleaseTermCommencedPeriod
P114M
CY2016 nktr Sublease Term Commenced End Date
SubleaseTermCommencedEndDate
2020-01-31
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3200000
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3200000
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3200000
CY2016Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
6600000
CY2015Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
8500000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
5037000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
5187000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
5344000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
452000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
16020000
CY2016 nktr Partial Repayment Of Royalty Sale Proceeds
PartialRepaymentOfRoyaltySaleProceeds
0
CY2016Q4 nktr Liability Related To Sale Of Potential Future Royalties Non Current
LiabilityRelatedToSaleOfPotentialFutureRoyaltiesNonCurrent
108586000
CY2016Q4 nktr Liabilities On Sale Of Future Royalties Unamortized Transaction Costs
LiabilitiesOnSaleOfFutureRoyaltiesUnamortizedTransactionCosts
2636000
CY2012Q1 nktr Liability Related To Sale Of Potential Future Royalties Non Current
LiabilityRelatedToSaleOfPotentialFutureRoyaltiesNonCurrent
0
nktr Proceeds From Sale Of Potential Future Royalties
ProceedsFromSaleOfPotentialFutureRoyalties
124000000
nktr Partial Repayment Of Royalty Sale Proceeds
PartialRepaymentOfRoyaltySaleProceeds
10000000
nktr Non Cash Royalty Revenue Related To Sale Of Future Royalties
NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties
106999000
nktr Non Cash Interest Expense Related To Sale Of Royalties
NonCashInterestExpenseRelatedToSaleOfRoyalties
101585000
CY2016 nktr Royalty Agreement Contingent Payment Description
RoyaltyAgreementContingentPaymentDescription
As a result of worldwide net sales of MIRCERA? for the 12 month periods ended December?31, 2013 and 2012 not reaching certain minimum thresholds.
CY2016 nktr Estimated Annual Interest Rate On Royalty Liability
EstimatedAnnualInterestRateOnRoyaltyLiability
0.17
CY2016 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
3700000
CY2015 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
2800000
CY2014 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
3400000
CY2016Q4 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
5800000
CY2015Q3 nktr Damage Claim For Alleged Unpaid Licensing Fee
DamageClaimForAllegedUnpaidLicensingFee
1500000
CY2016Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2015Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2016Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
189700000
CY2016 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.60
CY2016 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1100000
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
900000
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
900000
CY2016 nktr Change In Control Severance Payment Period For Executives
ChangeInControlSeverancePaymentPeriodForExecutives
P12M
CY2016 nktr Change In Control Severance Payment Period For Employees
ChangeInControlSeverancePaymentPeriodForEmployees
P6M
CY2016 nktr Change In Control Cash Severance Payment For To Chief Executive Officer
ChangeInControlCashSeverancePaymentForToChiefExecutiveOfficer
24 months base salary plus annual target incentive pay
CY2016 nktr Potential Development Milestones
PotentialDevelopmentMilestones
147000000
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
71200000
CY2016 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M18D
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.014
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.016
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.016
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.517
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.508
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.516
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M18D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M18D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y2M12D
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-155375000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-81931000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-56414000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
2727000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1260000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1986000
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-1000
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-1000
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
992000
CY2015 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
529000
CY2014 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-482000
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
991000
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
528000
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-481000
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-115000
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-22000
CY2014 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-31000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-115000
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-22000
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-31000
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-53427000
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-28235000
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-19050000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
51981000
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
22210000
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
11831000
CY2016 nktr Income Tax Reconciliation Non Deductible Expense For Liability Related Sale Of Future Royalties
IncomeTaxReconciliationNonDeductibleExpenseForLiabilityRelatedSaleOfFutureRoyalties
6899000
CY2015 nktr Income Tax Reconciliation Non Deductible Expense For Liability Related Sale Of Future Royalties
IncomeTaxReconciliationNonDeductibleExpenseForLiabilityRelatedSaleOfFutureRoyalties
7217000
CY2014 nktr Income Tax Reconciliation Non Deductible Expense For Liability Related Sale Of Future Royalties
IncomeTaxReconciliationNonDeductibleExpenseForLiabilityRelatedSaleOfFutureRoyalties
7311000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
528000
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
674000
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
2832000
CY2016 us-gaap Income Tax Reconciliation Tax Settlements Foreign
IncomeTaxReconciliationTaxSettlementsForeign
0
CY2015 us-gaap Income Tax Reconciliation Tax Settlements Foreign
IncomeTaxReconciliationTaxSettlementsForeign
1773000
CY2014 us-gaap Income Tax Reconciliation Tax Settlements Foreign
IncomeTaxReconciliationTaxSettlementsForeign
0
CY2016 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
4543000
CY2015 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
4529000
CY2014 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
2933000
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-562000
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1396000
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-503000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
508406000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
612996000
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
14698000
CY2016Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
13690000
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
7974000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
447761000
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
74917000
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
70258000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
26357000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
22832000
CY2016Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
23035000
CY2015Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
29658000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
12269000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
8309000
CY2016Q4 nktr Deferred Tax Assets Capitalized Research Expenses
DeferredTaxAssetsCapitalizedResearchExpenses
11587000
CY2015Q4 nktr Deferred Tax Assets Capitalized Research Expenses
DeferredTaxAssetsCapitalizedResearchExpenses
12440000
CY2016Q4 nktr Deferred Tax Assets Depreciation Property And Equipment
DeferredTaxAssetsDepreciationPropertyAndEquipment
6882000
CY2015Q4 nktr Deferred Tax Assets Depreciation Property And Equipment
DeferredTaxAssetsDepreciationPropertyAndEquipment
6451000
CY2016Q4 nktr Deferred Tax Assets From Sale Of Future Royalties
DeferredTaxAssetsFromSaleOfFutureRoyalties
1611000
CY2015Q4 nktr Deferred Tax Assets From Sale Of Future Royalties
DeferredTaxAssetsFromSaleOfFutureRoyalties
12319000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
750000
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3158000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
665814000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
613186000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
665514000
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
300000
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
190000
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
300000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
190000
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
52500000
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
17300000
CY2016 nktr Valuation Allowance Related To Stock Based Compensation And Exercises
ValuationAllowanceRelatedToStockBasedCompensationAndExercises
35600000
CY2015 nktr Valuation Allowance Related To Stock Based Compensation And Exercises
ValuationAllowanceRelatedToStockBasedCompensationAndExercises
35600000
CY2016Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
3400000
CY2016 nktr Federal Orphan Drug Credits
FederalOrphanDrugCredits
17700000
CY2016 nktr Federal Orphan Drug Credits Expiration Year
FederalOrphanDrugCreditsExpirationYear
2026
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17384000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
27522000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
16363000
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
0
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
0
CY2014 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
0
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
11110000
CY2014 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
742000
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0
CY2014 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0
CY2016 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0
CY2015 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0
CY2014 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
18413000
CY2016 nktr Unrecognized Tax Benefits Period Increase Decrease Reasonable Period Of Change
UnrecognizedTaxBenefitsPeriodIncreaseDecreaseReasonablePeriodOfChange
Next twelve months
CY2016 nktr Number Of Operating Business Segment
NumberOfOperatingBusinessSegment
1
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
14099000
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
12867000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9484000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-38325000
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10968000
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
7240000
CY2015Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
13973000
CY2016Q1 us-gaap Revenues
Revenues
58882000
CY2016Q2 us-gaap Revenues
Revenues
32768000
CY2016Q3 us-gaap Revenues
Revenues
36336000
CY2016Q4 us-gaap Revenues
Revenues
37450000
CY2015Q1 us-gaap Revenues
Revenues
108801000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-32901000
CY2015Q2 us-gaap Revenues
Revenues
22661000
CY2015Q3 us-gaap Revenues
Revenues
59952000
CY2015Q4 us-gaap Revenues
Revenues
39370000
CY2016Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
8870000
CY2016Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7708000
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7033000
CY2016Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
6604000
CY2015Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
8444000
CY2015Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
10534000
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
6760000
CY2015Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
8364000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49268000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52350000
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51951000
CY2016Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
50232000
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47011000
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45412000
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43229000
CY2015Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47135000
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-32145000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
43043000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-43469000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
419000
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-29364000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-19498000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-48603000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-43224000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-42199000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
33820000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-52657000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-8203000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-54137000
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.32
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40

Files In Submission

Name View Source Status
0001564590-17-003064-index-headers.html Edgar Link pending
0001564590-17-003064-index.html Edgar Link pending
0001564590-17-003064.txt Edgar Link pending
0001564590-17-003064-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2017030114142400117154.jpg Edgar Link pending
nktr-10k_20161231.htm Edgar Link pending
nktr-20161231.xml Edgar Link completed
nktr-20161231.xsd Edgar Link pending
nktr-20161231_cal.xml Edgar Link unprocessable
nktr-20161231_def.xml Edgar Link unprocessable
nktr-20161231_lab.xml Edgar Link unprocessable
nktr-20161231_pre.xml Edgar Link unprocessable
nktr-ex211_11.htm Edgar Link pending
nktr-ex231_6.htm Edgar Link pending
nktr-ex311_8.htm Edgar Link pending
nktr-ex312_7.htm Edgar Link pending
nktr-ex321_10.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending